Nicolas Poirier

Vorstandsvorsitzender bei OSE IMMUNOTHERAPEUTICS

Vermögen: 1 Mio $ am 30.04.2024

42 Jahre

Consumer Services

Health Technology

Aktive Positionen von Nicolas Poirier

Unternehmen	Position	Beginn	Ende
OSE IMMUNOTHERAPEUTICS	Direktor/Vorstandsmitglied	26.06.2019	-
	Vorstandsvorsitzender	07.10.2022	-
	Technik-/Wissenschafts-/F&E-Leiter	31.05.2016	07.10.2022

Unternehmen	Position	Beginn	Ende
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Corporate Officer/Principal	01.01.2012	-

Centre d'Etudes Supérieures de Techniques Industrielles	Undergraduate Degree
University of Nantes	Graduate Degree
Louis Pasteur University	Graduate Degree

International

Frankreich

Operativ

Sektoral

Consumer Services	4
Health Technology	3

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
OSE IMMUNOTHERAPEUTICS	Health Technology

Private Unternehmen	1
Effimune SA Effimune SA BiotechnologyHealth Technology Effimune SA engages in the research and development of drugs for transplantation and immune-mediated diseases. It covers the identification of novel therapeutic targets, the development of therapeutics, pilot manufacturing, set-up of animal models, pre-clinical and early clinical development. The company was founded by Maryvonne Hiance, Bernard Vanhove and Sophie Brouard in 2007 and is headquartered in Nantes, France.	Health Technology

Private Unternehmen

Health Technology